How a European pharma leader achieved 180% revenue growth in 24 months

A case study on market repositioning and local manufacturing strategy in the pharmaceutical sector.

Hiba Bagour

Partner, Market Operations

How a European pharma leader achieved 180% revenue growth in 24 months

PAPER

The Repositioning Challenge

A leading European pharmaceutical firm faced stagnating growth in the Moroccan market. By shifting from a pure import model to a 'local manufacturing + regional export' strategy, they unlocked a new phase of hyper-growth. This case study details the 24-month transformation.

Strategic Pivot

1

Local Production Hub:

Establishing a GMP-certified facility in the Casablanca region to serve both the domestic market and West Africa.

2

Portfolio Localization:

Adapting the product mix to meet the specific health priorities and price points of the Moroccan consumer.

3

Strategic Public Partnerships:

Aligning with the Ministry of Health's universal coverage roadmap to ensure long-term market access.

This briefing was verified by the Linc&Partners Research Council.

Strategic Takeaway

For organizations seeking to capitalize on these shifts, the window of operational advantage remains open but requires immediate regulatory alignment.